Cancer Genomics & Personalised Medicine 2018

Країна: Австрія

Місто: Vienna

Тези до: 19.06.2018

Дати: 18.08.18 — 20.08.18

Область наук: Біологічні; Медичні;

Е-мейл Оргкомітету: https://www.biomarkersummit.org/registration

Організатори: European Research Conclave

 

Precision medicine is a phrase that is often used to describe how genetic information about a person’s disease is being used to diagnose or treat their disease. Cancer is a disease of the genome and as more is learned about cancer tumors, the more we are finding that each tumor has its own set of genetic changes. Understanding the genetic changes that are in cancer cells is leading to more effective treatment strategies that are tailored to the genetic profile of each patient’s cancer.

Cancer genomics aims to advance personalized medicine through the DNA sequencing  and analysis of patient tumors to find new genetic alterations associated with specific cancers. Providing researchers with comprehensive catalogs of the key genomic changes in many major types and subtypes of cancer will support advances in developing more effective ways to diagnose, treat and prevent cancer.

Cancer Genomics & Personalised Medicine Summit-2018 is a forum for describing the development of genome-scale technologies and their applications. It aims to identify the recent advances in genome technologies and the ensuing outpouring of genomic information related to cancer which has accelerated the convergence of discovery science and clinical medicine. Translating cancer genomics into therapeutics and diagnostics reinforce its potential to make possible personalized cancer medicine. The summit is focussed on the importance of establishing the biological relevance of a cancer genomic discovery in realizing its clinical potential and discussing some of the major obstacles to moving from the bench to the bedside.

Cancer Genomics & Personalised Medicine Summit-2018 organised by Subhadra Healthcare, an emerging healthcare networking and consulting firm. The conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer immunogenomics and epigenomics, cancer mouse models and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

We sincerely hope that the blend of pleasant weather, warm hospitality and revitalizing social evenings will make the scientific environment richer. We look forward to the honor of welcoming you in Austria.

Topics of Interest

  • Structural Genomics and Cancer

  • Systems Biology and Drivers of Cancer

  • Cancer Immunogenomics

  • Cancer Genome and Epigenome

  • Cancer Genome Medicine

  • Immunology In The Age of Single Cell Genomics

  • Towards Deciphering the Functional Genetic and Neo Antigenic Landscape in Cancer

  • T Cell Recognition of Human Cancer

  • Exploiting Acquired Vulnerabilities of Drug Resistant Tumours

  • Precision Medicine

  • Clonal and Cellular Heterogeneity Landscapes of Cancer

  • Role of Rare Mutations in the onset of Cancer

  • Tumour Genomes Shed Light into Mutational Processes and Cancer Vulnerabilities

  • Molecular Analysis of Circulating Tumour Cells

  • Inferring Expressed Genes by Whole-Genome Sequencing of Plasma DNA

  • Predicting Relapse Using Circulating Tumour DNA

  • Patient-Derived Primary Cancer Cells, Integrative Omics and Functional Drug Testing

  • Tracking Cancer Evolution

  • Interrogating Cancer Genes with NGS-Based Approaches

  • Genotyping Technologies

  • Data Interpretation

  • Moving from Technology to Patient Treatment

  • The Evolving Role of the Patient

  • Cancer Genetics

  • Genomic Spectra of Cancers

  • Neurooncology- Next Generation Diagnostics Entering the Clinical Stage

  • Computational & Systems Biology of Cancer

  • The Heterogenous Landscape of Mutations and their Association with Genomic features

  • Cancer Drivers and their Therapeutic Opportunities

  • Cancer Predisposition in the Era of Next Generation Sequencing

  • Cancer Genome Biology

  • Analytics of Cancer Genome

  • Precision Oncology

  • Genome Guided Cancer Therapy

  • Big Data - Cancer Genome

  • Computational Characterization of Mutational Heterogeneity in Cancer

  • Cancer Functional Genomics and Epigenomics

  • Precision Medicine - Cancer Genomics & Beyond

  • Translating Cancer Genomics into Novel Drug Targets

  • Personalised Medicine - Changing the Landscape of Cancer

  • Transforming Cancer Research and Care

  • Personalised Immunotherapy

  • Technology & Sensors

  • Single Cell & Liquid Biopsy Genomics of Cancer

  • Translational & Clinical Genomics

 

Веб-сторінка конференції: https://www.biomarkersummit.org/